Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma

BACKGROUND: Chordoma is a rare, slow growing and locally aggressive mesenchymal neoplasm with uncommon distant metastases. It is a chemo-resistant disease with surgery and radiotherapy being the mainstay in treatment of localized disease. In advanced disease imatinib has a role. We report a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Saurav, Vadlamani, Surya Prakash, Shamim, Shamim Ahmed, Barwad, Adarsh, Rastogi, Sameer, Raj, S. T. Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733273/
https://www.ncbi.nlm.nih.gov/pubmed/33308288
http://dx.doi.org/10.1186/s13569-020-00149-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733273/
https://www.ncbi.nlm.nih.gov/pubmed/33308288
http://dx.doi.org/10.1186/s13569-020-00149-1

Ejemplares similares